Market Cap

HUTCHMED Ltd. Market Capitalization:

£1.75 Billion

GBP as of Jan. 1, 2026

US$2.36 Billion

business HUTCHMED Ltd. Company Profile

HUTCHMED Ltd. Main Stock Listing

LSE: HCM

Market Capitalization History of HUTCHMED Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of HUTCHMED Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 £1.75 B -9.63%
Jan. 1, 2025 £1.94 B -21.32%
Jan. 1, 2024 £2.47 B 0.57%
Jan. 1, 2023 £2.45 B -31.39%
Jan. 1, 2022 £3.57 B -8.33%
Jan. 1, 2021 £3.90 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

HUTCHMED Ltd. Categories

Hong Kong languages Healthcare languages Biotechnology
Hong Kong Healthcare Hong Kong Biotechnology

Stocks & Indices

HUTCHMED Ltd. has the following listings and related stock indices.


Stock: LSE: HCM

Stock: NASDAQ: HCM

Stock: FSX: H7T1

Stock: FSX: H7T2

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.